Public 'bickering' between Downing Street and NHS England chief Simon Stevens is damaging an NHS already at risk of “catastrophic failure”, according to a new parli
Amgen has chalked up a victory in a patent infringement lawsuit with Regeneron over blockbuster ophthalmic drug Eylea and decided to launch its biosimilar in the US – even though the legal